Avicanna Enters into a Strategic Partnership with Tetra Bio-Pharma
February 14, 2022 07:30 ET | Avicanna Inc.
TORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical...
Avicanna.png
Avicanna Provides Q4-2021 Results and Corporate Highlights as well as Fiscal 2022 Guidance
February 02, 2022 07:30 ET | Avicanna Inc.
TORONTO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical...
Avicanna.png
Avicanna Announces Closing of Non-Brokered Private Placement of Convertible Debenture Units
January 28, 2022 17:00 ET | Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical Pioneer Knop Laboratorios S.A.
January 14, 2022 07:30 ET | Avicanna Inc.
Expansion and fortification of relationship since 2020 with established pharmaceutical company in Chile Supply of Avicanna’s active pharmaceutical ingredients for existing commercial and pipeline...
Avicanna.png
Avicanna Announces the Appointment of Stephen Kim as Chief Legal Officer & General Counsel
January 10, 2022 07:30 ET | Avicanna Inc.
TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Avicanna USA Inc. together with Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on...
Avicanna.png
Avicanna Announces Changes to its Board of Directors
January 04, 2022 07:30 ET | Avicanna Inc.
TORONTO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing...
Avicanna Completes First Commercial Export of CBG Into the European Union
December 24, 2021 07:30 ET | Avicanna Inc.
First commercial export of Cannabigerol (CBG), a rare cannabinoid, into Czech Republic This export represents the 14th international market entrance for Avicanna products TORONTO, Dec. 24, 2021 ...
Avicanna Launches its Clinically Backed CBD Derma-cosmetics Brand, Pura H&W, in the United States in Partnership with Red White and Bloom
December 22, 2021 07:30 ET | Avicanna Inc.
The THC-Free, CBD derma-cosmetic brand is the first known CBD skincare line to be clinically tested and commercialized across four international markets The initial launch of Pura H&W will...
Avicanna and Harrington Wellness launch re+PLAY™ branded CBD topicals products in Canada
December 20, 2021 07:30 ET | Avicanna Inc.
re+PLAY is a sports performance and recovery-focused brand founded by NBA veteran Al Harrington with and evidence-based CBD formulations developed in partnership with Avicanna Products will be...
Avicanna.png
Avicanna to Participate in the Lytham Partners Winter 2021 Investor Conference
December 10, 2021 07:30 ET | Avicanna Inc.
TORONTO, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing,...